Replies to post #50004 on Easton Pharmaceuticals, Inc. (EAPH)

[mckinley1]

When EAPH adds MMJ Extracts to iBliss Products cannot even predict how high EAPH Revenues will rise as well as PPS.
"As previously announced, Easton has also closed on its acquisition of revenue producing iBliss Inc., a leading proprietary vaporizer and e-liquids manufacturer based in Toronto Canada possessing a growing list of International sales and clients. Since its closing, the Company has been working diligently negotiating new distribution agreements and strategic relationships. iBliss is on track to deliver revenues which it believes will match its record high of $15,000,000 per year due to new market launches and expansion on new and existing products."